ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,565Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 2456

$940K Total Retail Price of All Prescriptions

Rank: 44 out of 2456

926 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 926 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 926 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 16,047 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 1,282 1,078 1 2
LEVOTHYROXINE SODIUM 975 772 2 4
LISINOPRIL 919 771 3 1
OMEPRAZOLE 703 537 4 3
FUROSEMIDE 673 593 5 8
WARFARIN SODIUM 496 414 6 9
METOPROLOL TARTRATE 485 417 7 10
ATENOLOL 443 403 8 6
HYDROCODONE-ACETAMINOPHEN 434 373 S3 9 20
AMLODIPINE BESYLATE 402 381 10 5
METOPROLOL SUCCINATE 361 313 11 13
ATORVASTATIN CALCIUM 324 245 12 12
GABAPENTIN 307 269 13 16
TRAZODONE HCL 293 254 14 17
CITALOPRAM HBR 267 238 15 14
MIRTAZAPINE 266 264 16 29
DIVALPROEX SODIUM 247 228 17 51
TRAMADOL HCL 238 183 18 24
METFORMIN HCL 237 180 19 11
HYDROCHLOROTHIAZIDE 228 200 20 7
NAMENDA 214 214 21 42
LOSARTAN POTASSIUM 198 191 22 18
DONEPEZIL HCL 193 193 23 23
LORAZEPAM 178 177 24 67
ALLOPURINOL 169 154 25 27
LANTUS 139 119 26 44
LIDODERM 132 118 27 58
SERTRALINE HCL 126 84 28 21
ZOLPIDEM TARTRATE 125 109 29 28
RANITIDINE HCL 124 104 30 31
TAMSULOSIN HCL 122 105 31 32
POTASSIUM CHLORIDE 115 94 32 33
OXYCODONE HCL 108 70 S2 33 38
PROAIR HFA 107 63 34 22
CLOPIDOGREL 103 98 35 55
PAROXETINE HCL 103 86 35 56
OLANZAPINE 103 103 35 57
GLIPIZIDE 98 56 38 46
NIFEDIPINE ER 97 97 39 61
NOVOLOG 97 87 39 100
CIPROFLOXACIN HCL 96 89 41 87
POLYETHYLENE GLYCOL 3350 94 80 42 64
KLOR-CON M20 92 82 43 69
PREDNISONE 91 72 44 39
TRIAMTERENE-HCTZ 90 65 45 53
LEVETIRACETAM 88 60 46 90
DILTIAZEM 24HR ER 87 65 47 78
FAMOTIDINE 86 66 48 84
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 84 48 41
GLIPIZIDE ER 85 66 50 89
QUETIAPINE FUMARATE 85 76 50 47
FENOFIBRATE 84 32 52 68
SPIRIVA 83 67 53 43
PRAVASTATIN SODIUM 79 72 54 15
NEXIUM 78 39 55 80
PHENYTOIN SODIUM EXTENDED 78 53 55 140
FLUTICASONE PROPIONATE 78 51 55 30
LOVASTATIN 75 75 58 34
AZITHROMYCIN 72 50 59 60
FENTANYL 71 39 S2 60 115
ISOSORBIDE MONONITRATE ER 68 64 61 48
PANTOPRAZOLE SODIUM 67 37 62 37
VERAPAMIL ER 67 50 62 91
NYSTATIN 65 55 64 99
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 51 65 147
FINASTERIDE 63 63 66 66
CYMBALTA 63 47 66 65
LEVOFLOXACIN 61 53 68 103
ENALAPRIL MALEATE 61 37 68 70
OXYBUTYNIN CHLORIDE ER 61 48 68 94
CEPHALEXIN 61 54 68 153
FLUOXETINE HCL 60 57 72 45
ADVAIR DISKUS 57 48 73 36
GEMFIBROZIL 57 48 73 93
ESCITALOPRAM OXALATE 56 51 75 116
ROPINIROLE HCL 55 42 76 148
OXYCONTIN 54 37 S2 77 129
PLAVIX 54 54 77 79
TOPIRAMATE 52 0 79 162
NAPROXEN 52 28 79 109
BUPROPION HCL 50 50 81 210
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.